Risk of De Novo Inflammatory Bowel Disease in Patients With Psoriasis and Psoriatic Arthritis Treated With IL‐17A Inhibitors: A Population‐Based Study.
Saved in:
| Title: | Risk of De Novo Inflammatory Bowel Disease in Patients With Psoriasis and Psoriatic Arthritis Treated With IL‐17A Inhibitors: A Population‐Based Study. |
|---|---|
| Authors: | Alsakarneh, Saqr1 (AUTHOR), Al Ta'ani, Omar2 (AUTHOR) otaani19@gmail.com, Aburumman, Razan3 (AUTHOR), Mikhail, Inas4 (AUTHOR), Hashash, Jana G.4 (AUTHOR), Farraye, Francis A.4 (AUTHOR) |
| Source: | Alimentary Pharmacology & Therapeutics. Jul2025, Vol. 62 Issue 1, p72-76. 5p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 02692813 |
|---|---|
| DOI: | 10.1111/apt.70139 |
